References
  1. Matsuzaki S, Kimura T.Vasa Previa. N Engl J Med. 2019 Jan 17;380(3):274. doi: 10.1056/NEJMicm1808778.
  2. Pavalagantharajah S, Villani LA, D’Souza R. Vasa previa and associated risk factors: a systematic review and meta-analysis. Am J Obstet Gynecol MFM. 2020 Aug;2(3):100117. doi: 10.1016/j.ajogmf.2020.100117.
  3. Westcott JM, Simpson S, Chasen S, et al. Prenatally diagnosed vasa previa: association with adverse obstetrical and neonatal outcomes. Am J Obstet Gynecol MFM. 2020 Nov;2(4):100206. doi: 10.1016/j.ajogmf.2020.100206.
  4. Villani LA, Pavalagantharajah S, D’Souza R.Variations in reported outcomes in studies on vasa previa: a systematic review.Am J Obstet Gynecol MFM. 2020 Aug;2(3):100116. doi: 10.1016/j.ajogmf.2020.100116.
  5. Melcer Y, Maymon R, Jauniaux E.Vasa previa: prenatal diagnosis and management. Curr Opin Obstet Gynecol. 2018 Dec;30(6):385-391. doi: 10.1097/GCO.0000000000000478.
  6. Chmait RH, Catanzarite V, Chon AH. Fetoscopic Laser Ablation Therapy for Type II Vasa Previa. Fetal Diagn Ther. 2020;47(9):682-688. doi: 10.1159/000508044.
  7. Erfani H, Haeri S, Shainker SA, et al. Vasa previa: a multicenter retrospective cohort study. Am J Obstet Gynecol. 2019 Dec;221(6):644.e1-644.e5. doi: 10.1016/j.ajog.2019.06.006.
  8. James M Shwayder. Normal Pelvic Anatomy. Obstet Gynecol Clin North Am. 2019 Dec;46(4):563-580. doi: 10.1016/j.ogc.2019.06.001.
  9. Javid N, Hyett JA, Walker SP, et al. A survey of opinion and practice regarding prenatal diagnosis of vasa previa among obstetricians from Australia and New Zealand Int J Gynaecol Obstet. 2019 Mar;144(3):252-259. doi: 10.1002/ijgo.12747.
  10. McQueen V, Speed M, Rutter S, Gray T. Vasa praevia: Should we routinely screen high-risk women for this rare but serious condition? Ultrasound. 2018 May;26(2):127-131. doi: 10.1177/1742271X17747137.
  11. Mihoko Aoki, Soichiro Obata, Mizuha Odagami et al. Prenatal diagnosis of vasa previa and the course of the cord vessels contribute to the safety of cesarean sections: A case report.Clin Case Rep. 2019 Sep 27;7(11):2114-2117. doi: 10.1002/ccr3.2432.
  12. Iwahashi N, Ota N, Shiro M, et al. Vasa previa evaluated by noncontrast time-of-flight magnetic resonance angiography. Taiwan J Obstet Gynecol. 2016 Aug;55(4):585-7. doi: 10.1016/j.tjog.2016.06.007.
  13. Masselli G, Gualdi G. MR imaging of the placenta: what a radiologist should know. Abdom Imaging. 2013 Jun;38(3):573-87. doi: 10.1007/s00261-012-9929-8.
  14. Kikuchi A, Uemura R, Serikawa T, et al. Clinical significances of magnetic resonance imaging in prenatal diagnosis of vasa previa in a woman with bilobed placentas. J Obstet Gynaecol Res. 2011 Jan;37(1):75-8. doi: 10.1111/j.1447-0756.2010.01308.x.
  15. Podrasky AE, Javitt MC, Glanc P, et al. ACR appropriateness Criteria® second and third trimester bleeding. Ultrasound Q. 2013 Dec;29(4):293-301. doi: 10.1097/RUQ.0000000000000044.